- Home
- Publications
- Publication Search
- Publication Details
Title
Maintenance therapy options for ulcerative colitis
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 17, Issue 10, Pages 1339-1349
Publisher
Informa UK Limited
Online
2016-05-30
DOI
10.1080/14656566.2016.1187132
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis
- (2015) David S. Kotlyar et al. Clinical Gastroenterology and Hepatology
- Risk of Lymphoma, Colorectal and Skin Cancer in Patients with IBD Treated with Immunomodulators and Biologics
- (2015) Uri Kopylov et al. INFLAMMATORY BOWEL DISEASES
- Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort
- (2015) Krisztina B. Gecse et al. Journal of Crohns & Colitis
- Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea
- (2015) Sang Hyoung Park et al. Expert Review of Gastroenterology & Hepatology
- Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study
- (2015) Jørgen Jahnsen et al. Expert Review of Gastroenterology & Hepatology
- Association Between Thiopurine Use and Nonmelanoma Skin Cancers in Patients With Inflammatory Bowel Disease: A Meta-Analysis
- (2014) Jonathan Ariyaratnam et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2 and 3
- (2014) Jean-Frederic Colombel et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α
- (2014) David J. Shealy et al. mAbs
- A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia
- (2014) Suk-Kyun Yang et al. NATURE GENETICS
- Adalimumab in active ulcerative colitis: A “real-life” observational study
- (2013) Alessandro Armuzzi et al. DIGESTIVE AND LIVER DISEASE
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Adalimumab Therapy Is Associated With Reduced Risk of Hospitalization in Patients With Ulcerative Colitis
- (2013) Brian G. Feagan et al. GASTROENTEROLOGY
- Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
- (2013) Remo Panaccione et al. GASTROENTEROLOGY
- Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Safety of Thiopurine Therapy in Inflammatory Bowel Disease
- (2013) María Chaparro et al. INFLAMMATORY BOWEL DISEASES
- 11 Vedolizumab induction therapy for patients with Crohn's disease and prior anti-tumour necrosis factor antagonist failure: a randomised, placebo-controlled, double-blind, multicentre trial
- (2013) B. Sands et al. Journal of Crohns & Colitis
- Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: Rapid symptom resolution and improvements in quality of life
- (2013) Christopher S.J. Probert et al. Journal of Crohns & Colitis
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- New genetic associations in thiopurine-related bone marrow toxicity among inflammatory bowel disease patients
- (2013) William Zabala et al. PHARMACOGENOMICS
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
- (2012) Axel Dignass et al. Journal of Crohns & Colitis
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
- (2012) Axel Dignass et al. Journal of Crohns & Colitis
- Efficacy of Adalimumab as a long term maintenance therapy in ulcerative colitis
- (2012) Edel McDermott et al. Journal of Crohns & Colitis
- Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome
- (2012) Orlando García-Bosch et al. Journal of Crohns & Colitis
- Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
- (2012) David Laharie et al. LANCET
- Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients
- (2011) Y. González-Lama et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysis
- (2011) L. Leifeld et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study
- (2011) M. Chaparro et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: A single-center cohort study
- (2011) Livia Biancone et al. Journal of Crohns & Colitis
- Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
- (2010) C. Taxonera et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort
- (2010) N. Gies et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hepatosplenic T-Cell Lymphoma in Inflammatory Bowel Disease: A Possible Thiopurine-Induced Chromosomal Abnormality
- (2010) David S Kotlyar et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
- (2010) Asher Kornbluth et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful
- (2010) S. Ben-Horin et al. GUT
- Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
- (2009) J. P. GISBERT et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
- (2009) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Infliximab Rescue Therapy after Cyclosporin Failure in Steroid-Refractory Ulcerative Colitis
- (2009) Míriam Mañosa et al. DIGESTION
- Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
- (2009) William J. Sandborn et al. GASTROENTEROLOGY
- Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab
- (2009) Waqqas Afif et al. INFLAMMATORY BOWEL DISEASES
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- (2009) Laurent Beaugerie et al. LANCET
- Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience
- (2008) A. OUSSALAH et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Thiopurine-Induced Myelotoxicity in Patients With Inflammatory Bowel Disease: A Review
- (2008) Javier P. Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial
- (2008) W Kruis et al. GUT
- Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)
- (2008) Inger Camilla Solberg et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started